Prelude Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/17/2026 | 10.91 M | $31.64 M | 0.00% | 14.33% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 10.12 M | $29.36 M | 0.00% | 13.30% |
| VANGUARD GROUP INC | 01/29/2026 | 1.41 M | $4.10 M | 42.42% | 1.86% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 788.87 K | $2.29 M | 100.00% | 1.04% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 788.70 K | $2.29 M | 418.08% | 1.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 755.96 K | $2.19 M | -13.74% | 0.99% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 535.70 K | $1.55 M | -0.90% | 0.70% |
| MORGAN STANLEY | 02/13/2026 | 334.92 K | $971.26 K | 17.84% | 0.44% |
| MARSHALL WACE, LLP | 02/13/2026 | 273.88 K | $794.26 K | 100.00% | 0.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 272.89 K | $791.50 K | 25.43% | 0.36% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 271.30 K | $786.77 K | -50.13% | 0.36% |
| BLACKROCK, INC. | 02/12/2026 | 266.28 K | $772.21 K | 0.49% | 0.35% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 237.30 K | $688.17 K | 6.56% | 0.31% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 160.65 K | $465.89 K | 0.00% | 0.21% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 151.00 K | $437.89 K | -86.84% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 135.91 K | $394.14 K | 100.00% | 0.18% |
| STATE STREET CORP | 02/13/2026 | 127.29 K | $369.15 K | 30.43% | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 122.75 K | $355.98 K | 100.00% | 0.16% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 117.48 K | $340.68 K | 48.09% | 0.15% |
| JANE STREET GROUP, LLC | 02/12/2026 | 111.04 K | $322.02 K | 218.88% | 0.15% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 73.00 K | $211.70 K | 100.00% | 0.10% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 70.55 K | $200.43 K | 1.87% | 0.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 59.17 K | $171.59 K | 100.00% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 53.50 K | $155.15 K | 0.00% | 0.07% |
| XTX TOPCO LTD | 02/17/2026 | 50.16 K | $145.46 K | 221.99% | 0.07% |
| NORTHERN TRUST CORP | 02/17/2026 | 50.12 K | $145.35 K | 37.61% | 0.07% |
| COLONY GROUP, LLC | 02/13/2026 | 50.01 K | $145.02 K | 100.00% | 0.07% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 46.09 K | $133.66 K | 100.00% | 0.06% |
| CERITY PARTNERS LLC | 02/11/2026 | 32.95 K | $95.56 K | -4.02% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 32.50 K | $94.25 K | 100.00% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 21.55 K | $62.50 K | 100.00% | 0.03% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 15.52 K | $45.01 K | -39.94% | 0.02% |
| HSBC HOLDINGS PLC | 03/20/2026 | 13.65 K | $39.45 K | -0.69% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 9.81 K | $28.44 K | 10.85% | 0.01% |
| BARCLAYS PLC | 02/13/2026 | 8.60 K | $24.95 K | -1.26% | 0.01% |
| FMR LLC | 02/17/2026 | 6.15 K | $17.84 K | -32.39% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 2.74 K | $7.95 K | 0.00% | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 01/30/2026 | 2.00 K | $5.80 K | 100.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 1.86 K | $5.39 K | -55.48% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 1.74 K | $5.00 K | -77.41% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/15/2026 | 1.63 K | $4.74 K | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/06/2026 | 1.17 K | $3.40 K | 0.00% | 0.00% |
| CWM, LLC | 01/26/2026 | 692 | $2.00 K | -43.23% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 500 | $1.45 K | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 95 | $276 | 82.69% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 62 | $180 | -98.40% | 0.00% |
| OPTIVER HOLDING B.V. | 02/17/2026 | 20 | $58 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $3 | -99.98% | 0.00% |
| IFP ADVISORS, INC | 02/06/2026 | 1 | $3 | -94.44% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prelude Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Prelude Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 64,505
HSBC HOLDINGS PLC: 13,652
SBI Securities Co., Ltd.: 2,641
NISA INVESTMENT ADVISORS, LLC: 1,634
Fortitude Family Office, LLC: 230
IFP Advisors, Inc: 0
37.40% of Prelude Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 31.39 M shares in the last 24 months. This purchase volume represents approximately $96.99 M in transactions.